NCT04068896 : Clinical Trial Detail - Cancer Knowledgebase (CKB)

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT04068896
Title	Study of NGM120 in Subjects With Advanced Solid Tumors and Pancreatic Cancer Using Combination Therapy
Recruitment	Completed
Gender	both
Phase	Phase I
Variant Requirements	No
Sponsors	NGM Biopharmaceuticals, Inc
Indications	stomach cancer melanoma colorectal cancer pancreatic cancer esophageal cancer lung non-small cell carcinoma urinary bladder cancer head and neck squamous cell carcinoma ovarian cancer pancreatic adenocarcinoma prostate cancer
Therapies	NGM120
Age Groups:	adult \| senior
Covered Countries	USA

NCT04068896
Clinical Trial Detail